These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35802353)

  • 1. Diversity of NKG2C genotypes in a European population: Conserved and recombinant haplotypes in the coding, promoter, and 3'-untranslated regions.
    Asenjo J; Moraru M; Al-Akioui-Sanz K; Altadill M; Muntasell A; López-Botet M; Vilches C
    HLA; 2022 Nov; 100(5):469-478. PubMed ID: 35802353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the activating NKG2C receptor and a functional polymorphism in its ligand HLA-E in psoriasis susceptibility.
    Zeng X; Chen H; Gupta R; Paz-Altschul O; Bowcock AM; Liao W
    Exp Dermatol; 2013 Oct; 22(10):679-81. PubMed ID: 24079744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
    Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
    Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
    Ding Y; Sumitran S; Holgersson J
    Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of copy-number variation in the NKG2C receptor gene in a single-tube and characterization of a reference cell panel, using standard polymerase chain reaction.
    Moraru M; Cañizares M; Muntasell A; de Pablo R; López-Botet M; Vilches C
    Tissue Antigens; 2012 Aug; 80(2):184-7. PubMed ID: 22708664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
    Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2C copy number variations in five distinct populations in mainland China and susceptibility to nasopharyngeal carcinoma (NPC).
    Li L; Tian W; Wang W; Liu K; Wang J; Jin H; Cai J; Wang J
    Hum Immunol; 2015 Mar; 76(2-3):90-4. PubMed ID: 25636564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of the NKG2C NK cell response against Puumala Orthohantavirus.
    Vietzen H; Hartenberger S; Aberle SW; Puchhammer-Stöckl E
    PLoS Negl Trop Dis; 2021 Dec; 15(12):e0010006. PubMed ID: 34871302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus.
    Muntasell A; López-Montañés M; Vera A; Heredia G; Romo N; Peñafiel J; Moraru M; Vila J; Vilches C; López-Botet M
    Eur J Immunol; 2013 Dec; 43(12):3268-78. PubMed ID: 24030638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
    J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
    Heatley SL; Pietra G; Lin J; Widjaja JML; Harpur CM; Lester S; Rossjohn J; Szer J; Schwarer A; Bradstock K; Bardy PG; Mingari MC; Moretta L; Sullivan LC; Brooks AG
    J Biol Chem; 2013 Mar; 288(12):8679-8690. PubMed ID: 23335510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes.
    Shum BP; Flodin LR; Muir DG; Rajalingam R; Khakoo SI; Cleland S; Guethlein LA; Uhrberg M; Parham P
    J Immunol; 2002 Jan; 168(1):240-52. PubMed ID: 11751968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
    J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.
    Gumá M; Angulo A; Vilches C; Gómez-Lozano N; Malats N; López-Botet M
    Blood; 2004 Dec; 104(12):3664-71. PubMed ID: 15304389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversification of both KIR and NKG2 natural killer cell receptor genes in macaques - implications for highly complex MHC-dependent regulation of natural killer cells.
    Walter L; Petersen B
    Immunology; 2017 Feb; 150(2):139-145. PubMed ID: 27565739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications.
    Siemaszko J; Marzec-Przyszlak A; Bogunia-Kubik K
    Arch Immunol Ther Exp (Warsz); 2023 Mar; 71(1):9. PubMed ID: 36899273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.